39.41
1.08%
+0.42
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVMD Giù?
Forum
Previsione
Revolution Medicines Inc Azioni (RVMD) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
0.742
|
- | 3.824 | 7.014 | 15.33 |
Operating Expenses
|
46.64%
180.72
|
123.25 | 112.62 | 82.17 | 77.04 |
Benefits Costs and Expenses |
44.20%
161.94
|
112.30 | 102.12 | 75.11 | 71.96 |
Costs And Expenses |
44.20%
161.94
|
112.30 | 102.12 | 75.11 | 71.96 |
Operating Income/Loss |
46.03%
-179.98
|
-123.25 | -108.80 | -75.16 | -61.71 |
Nonoperating Income/Loss |
71.64%
18.79
|
10.95 | 10.50 | 7.059 | 5.077 |
Income/Loss From Continuing Operations Before Tax |
43.54%
-161.19
|
-112.30 | -98.30 | -68.10 | -56.63 |
Income Tax Expense/Benefit |
108.87%
0.343
|
-3.867 | - | - | -0.123 |
Income/Loss From Continuing Operations After Tax |
48.97%
-161.54
|
-108.43 | -98.30 | -68.10 | -56.51 |
Net Income/Loss
|
48.97%
-161.54
|
-108.43 | -98.30 | -68.10 | -56.51 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
91.35%
9.4474
|
109.23 | 106.88 | 94.83 | 2.8753 |
Diluted Average Shares |
91.35%
9.4474
|
109.23 | 106.88 | 94.83 | 2.8753 |
Basic Earnings Per Share |
22.22%
-1.21
|
-0.99 | -0.92 | -0.72 | -0.61 |
Diluted Earnings Per Share |
22.22%
-1.21
|
-0.99 | -0.92 | -0.72 | -0.61 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):